Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor β1- and slug-dependent: Role in malignant transformation of pancreatic cancer

Cancer Research

Volumn 69, Issue 10, 2009, Pages 4517-4526

  Geismann, Claudia ^a   Morscheck, Mascha ^a   Koch, Dorothee ^a   Bergmann, Frank ^b   Ungefroren, Hendrik ^a   Arlt, Alexander ^a   Tsao, Ming Sound ^d   Bachem, Max G ^e   Altevogt, Peter ^c   Sipos, Bence ^a   Fölsch, Ulrich R ^a   Schäfer, Heiner ^a   Müerköster, Susanne Sebens ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE L1; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CARCINOGENESIS; CHRONIC PANCREATITIS; COCULTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MONOCULTURE; MOUSE; MYOFIBROBLAST; NONHUMAN; PANCREAS CANCER; PANCREAS CELL; PANCREAS DUCT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; STAINING; UPREGULATION;

ADENOCARCINOMA; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; COCULTURE TECHNIQUES; HUMANS; MICE; NEURAL CELL ADHESION MOLECULE L1; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATITIS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 66249104020     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3493     Document Type: Article

References (45)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005;128:1606-1625 (Pubitemid 40692555)
3. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002;10:153-169
4. Luttges J, Kloppel G. [Pancreatic ductal adenocarcinoma and its precursors]. Pathologe 2005;26:12-17
5. Yen TW, Aardal NP, Bronner MP, et al. Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 2002;131:129-134 (Pubitemid 34169536)
6. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-337 (Pubitemid 39551661)
7. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002;70:486-497 (Pubitemid 36194314)
8. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36. (Pubitemid 32060576)
9. Guarino M. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 2007;39:2153-2160 (Pubitemid 47484287)
10. Ellenrieder V, Buck A, Gress TM. TGFβ-regulated transcriptional mechanisms in cancer. Int J Gastrointest Cancer 2002;31:61-69 (Pubitemid 36330107)
11. Ellenrieder V, Hendler SF, Boeck W, et al. Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 2001;61:4222-4228 (Pubitemid 32720992)
12. Zavadil J, Bottinger EP. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005;24:5764-5774
13. Moustakas A, Heldin CH. Non-Smad TGF-β signals. J Cell Sci 2005;118:3573-3584
14. Dumont N, Bakin AV, Arteaga CL. Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 2003;278 :3275-3285 (Pubitemid 36801240)
15. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci 2004;117:4619-4628 (Pubitemid 39433429)
16. Imamichi Y, Waidmann O, Hein R, Eleftheriou P, Giehl K, Menke A. TGF β-induced focal complex formation in epithelial cells is mediated by activated ERK, JNK MAP. kinases and is independent of Smad4. Biol Chem 2005;386:225-236
17. Barallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005;132:3151-3161 (Pubitemid 41167144)
18. Fogel M, Gutwein P, Mechtersheimer S, et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 2003a;362:869-875 (Pubitemid 37130096)
19. Fogel M, Mechtersheimer S, Huszar M, et al. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett 2003b;189:237-247 (Pubitemid 35462000)
20. Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005;168:633-642 (Pubitemid 40271028)
21. Sebens Muerkoster S, Werbing V, Sipos B, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 2007;26:2759-2768 (Pubitemid 46663831)
22. Arlt MJ, Novak-Hofer I, Gast D, et al. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 2006;66:936-943 (Pubitemid 43165961)
23. 3 integrin expression in ovarian carcinomas. Int J Cancer 2005;115:658-665
24. Stoeck A, Gast D, Sanderson MP, Issa Y, Gutwein P, Altevogt P. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 2007;104:461-469 (Pubitemid 46156956)
25. Ouyang H, Mou L, Luk C, et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 2000;157:1623-1631
26. Furukawa T, Duguld WP, Rosenberg L, Vlallet J, Galloway DA, Tsao M-S. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996;148:1763-1770 (Pubitemid 26171674)
27. Liu N, Furukawa T, Kobari M, Tsao MS. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol 1998;153:263-269 (Pubitemid 28317529)
28. Sebens Muerkoster S, Werbing V, Koch D, et al. Role of myofibroblasts on innate chemoresistance in pancreatic carcinoma - epigenetic down-regulation of caspases. Int J Cancer 2008;123:1751-1760
29. Moore PS, Sipos B, Orlandini S, et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 2001;439:798-802.
30. Dai JL, Turnacioglu KK, Schutte M, Sugar AY, Kern SE. Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res 1998;58:4592-4597 (Pubitemid 28480621)
31. Bachem MG, Schunemann M, Ramadani M, et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005;128:907-921 (Pubitemid 40523543)
32. Muerkoster S, Wegehenkel K, Arlt A, et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1β. Cancer Res 2004;64:1331-1337 (Pubitemid 38235601)
33. Schafer H, Diebel J, Arlt A, Trauzold A, Schmidt WE. The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFκB. FEBS Lett 1998;436:139-143 (Pubitemid 28468543)
34. Chen WB, Lenschow W, Tiede K, Fischer JW, Kalthoff H, Ungefroren H. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-β in pancreatic tumor cells. J Biol Chem 2002;277:36118-36128
35. Satoh K, Shimosegawa T, Hirota M, Koizumi M, Toyota T. Expression of transforming growth factor β1 (TGFβ1) and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis. Pancreas 1998;16:468-474 (Pubitemid 28217532)
36. Perides G, Safran RM, Downing LA, Charness ME. Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-β superfamily. J Biol Chem 1994;269:765-770
37. Pancook JD, Reisfeld RA, Varki N, Vitiello A, Fox RI, Montgomery AMP. Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. J Immunol 1997;158:4413-4421 (Pubitemid 127483945)
38. Giehl K, Imamichi Y, Menke A. Smad4-independent TGF-β signaling in tumor cell migration. Cells Tissues Organs 2007;185:123-130 (Pubitemid 46956853)
39. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003;424:219-223 (Pubitemid 36858692)
40. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999;1:260-266 (Pubitemid 129495775)
41. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr H-J, Hotz HG. Epithelial to mesenchymal transition: expression of regulators Snail, Slug, and Twist in pancreatic cancer. Clin Cancer Res 2007;13:4769-4776
42. Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res 2006;66:11370-11380 (Pubitemid 46009968)
43. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 2004;279:28880-28888 (Pubitemid 38915755)
44. Gast D, Riedle S, Issa Y, et al. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 2008;27:1281-1289
45. Del Castillo G, Murillo MM, Alvarez-Barrientos A, et al. Autocrine production of TGF-β confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: role of EGF receptor ligands. Exp Cell Res 2006;312:2860-2871 (Pubitemid 44246942)